πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7198788

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing C

The Board of Regents of the University of Texas System Β· Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7183401

NOEY2 gene compositions and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7179894

Combinatorial selection of oligonucleotide aptamers

The Board of Regents of the University of Texas System Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7179588

Assay for the detection of paclitaxel resistant cells in human tumors

The Board of Regents of the University of Texas System Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7175848

Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolize

The Board of Regents of the University of Texas System Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7176302

Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides

The Board of Regents of the University of Texas System Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7172770

Mesoporous compositions for use in drug delivery

The Board of Regents of the University of Texas System Β· Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7169384

Tumor suppressor CAR-1

The Board of Regents of the University of Texas System Β· Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7163925

p16 expression constructs and their application in cancer therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7160720

CHAMPβ€”a novel cardiac helicase-like factor

The Board of Regents of the University of Texas System Β· Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7160722

Master bone formation transcription factor: compositions and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7153519

Implantable substrate coated with a macromer having free radical polymerizable substituent

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7153838

Pharmacologically acceptable solvent vehicles

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7153683

TAO protein kinase polypeptides and methods of use therefor

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7141405

Chimeric GB virus B (GBV-B)

The Board of Regents of the University of Texas System Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7135176

VMP-like sequences of pathogenic Borrelia

The Board of Regents of the University of Texas System Β· Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7129039

Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and u

The Board of Regents of the University of Texas System Β· Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7122572

Calixpyrroles

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7119064

Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of int

The Board of Regents of the University of Texas System Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7115577

Colorectal neoplasia prophylaxis

The Board of Regents of the University of Texas System Β· Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7112317

Combined methods and compositions for tumor vasculature targeting and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7109188

Methods and compositions for treating atheroma, tumors and other neoplastic tissue

The Board of Regents of the University of Texas System Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7109179

Methods and compositions comprising DNA damaging agents and p53

The Board of Regents of the University of Texas System Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7101852

Composition and method for treatment and prevention of restenosis

The Board of Regents of the University of Texas System Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted